UMLS CUI | C0024141 |
UMLS Term | Lupus Erythematosus, Systemic |
MeSH ID | D008180 |
MeSH Term | Lupus Erythematosus, Systemic |
Disease Classes |
Skin and Connective Tissue Diseases Immune System Diseases |
Gene Symbol | Description | Entrez ID | Uniprot ID | Chromosomal Location |
---|---|---|---|---|
SH2B3 |
SH2B adaptor protein 3 |
10019 |
Q9UQQ2 |
chr12: 111,405,948-111,451,623 |
CDKN1B |
cyclin-dependent kinase inhibitor 1B (p27, Kip1) |
1027 |
P46527 |
chr12: 12,715,058-12,722,371 |
IKZF1 |
IKAROS family zinc finger 1 |
10320 |
Q13422 |
chr7: 50,304,124-50,405,101 |
CLU |
clusterin |
1191 |
P10909 |
chr8: 27,596,917-27,615,031 |
SLC15A4 |
solute carrier family 15 (oligopeptide transporter), member 4 |
121260 |
Q8N697 |
chr12: 128,793,191-128,823,983 |
CREBL2 |
cAMP responsive element binding protein-like 2 |
1389 |
O60519 |
chr12: 12,611,827-12,645,108 |
CRP |
C-reactive protein, pentraxin-related |
1401 |
P02741 |
chr1: 159,712,289-159,714,589 |
CSK |
c-src tyrosine kinase |
1445 |
P41240 |
chr15: 74,782,057-74,803,198 |
ETS1 |
v-ets avian erythroblastosis virus E26 oncogene homolog 1 |
2113 |
P14921 |
chr11: 128,458,761-128,587,558 |
FCGR2A |
Fc fragment of IgG, low affinity IIa, receptor (CD32) |
2212 |
P12318 |
chr1: 161,505,430-161,524,013 |
FCGR2B |
Fc fragment of IgG, low affinity IIb, receptor (CD32) |
2213 |
P31994 |
chr1: 161,663,147-161,678,654 |
JAZF1 |
JAZF zinc finger 1 |
221895 |
Q86VZ6 |
chr7: 27,830,573-28,180,743 |
ANKS1A |
ankyrin repeat and sterile alpha motif domain containing 1A |
23294 |
Q92625 |
chr6: 34,889,265-35,091,413 |
TNPO3 |
transportin 3 |
23534 |
Q9Y5L0 |
chr7: 128,954,180-129,055,173 |
PTPN22 |
protein tyrosine phosphatase, non-receptor type 22 (lymphoid) |
26191 |
Q9Y2R2 |
chr1: 113,813,811-113,871,759 |
FAM98B |
family with sequence similarity 98 member B |
283742 |
Q52LJ0 |
chr15: 38,454,127-38,487,710 |
ANXA3 |
annexin A3 |
306 |
P12429 |
chr4: 78,551,519-78,610,451 |
HIP1 |
huntingtin interacting protein 1 |
3092 |
O00291 |
chr7: 75,533,300-75,738,962 |
HLA-DQA1 |
major histocompatibility complex, class II, DQ alpha 1 |
3117 |
P01909 |
chr6: 32,628,179-32,647,062 |
HLA-DRB1 |
major histocompatibility complex, class II, DR beta 1 |
3123 |
P04229 |
chr6: 32,578,769-32,589,848 |
IL6 |
interleukin 6 |
3569 |
P05231 |
chr7: 22,725,884-22,732,002 |
IL10 |
interleukin 10 |
3586 |
P22301 |
chr1: 206,767,602-206,772,494 |
ITGAM |
integrin subunit alpha M |
3684 |
P11215 |
chr16: 31,259,990-31,332,892 |
ITGAX |
integrin subunit alpha X |
3687 |
P20702 |
chr16: 31,355,134-31,382,997 |
PXK |
PX domain containing serine/threonine kinase |
54899 |
Q7Z7A4 |
chr3: 58,332,880-58,426,126 |
PRL |
prolactin |
5617 |
P01236 |
chr6: 22,287,244-22,297,501 |
PTGS2 |
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) |
5743 |
P35354 |
chr1: 186,671,791-186,680,427 |
PHRF1 |
PHD and ring finger domains 1 |
57661 |
Q9P1Y6 |
chr11: 576,486-612,222 |
CFB |
complement factor B |
629 |
P00751 |
chr6: 31,945,650-31,952,084 |
TLR5 |
toll-like receptor 5 |
7100 |
O60602 |
chr1: 223,109,406-223,143,282 |
C1QA |
complement component 1, q subcomponent, A chain |
712 |
P02745 |
chr1: 22,636,506-22,639,608 |
TNFAIP3 |
TNF alpha induced protein 3 |
7128 |
P21580 |
chr6: 137,867,188-137,883,312 |
TNXB |
tenascin XB |
7148 |
P22105 |
chr6: 32,041,154-32,115,334 |
C4A |
complement component 4A (Rodgers blood group) |
720 |
P0C0L4 |
chr6: 31,982,024-32,002,681 |
TNFSF4 |
tumor necrosis factor superfamily member 4 |
7292 |
P23510 |
chr1: 173,183,734-173,207,313 |
DDA1 |
DET1 and DDB1 associated 1 |
79016 |
Q9BW61 |
chr19: 17,309,518-17,323,301 |
KIAA0319L |
KIAA0319-like |
79932 |
Q8IZA0 |
chr1: 35,433,490-35,557,950 |
ARID5B |
AT-rich interaction domain 5B |
84159 |
Q14865 |
chr10: 61,901,300-62,096,944 |